Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Analyzing Real-World Infection Risk in Multiple Myeloma Patients Receiving Teclistamab.
Journal: Current oncology (Toronto, Ont.)
Published: January 10, 2026
Evolution of Allogeneic Stem Cell Transplantation: Main Focus on AML.
Journal: Cells
Published: March 13, 2025
Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation.
Journal: British journal of haematology
Published: January 11, 2025
Cytokine modification by the RNA regulatory protein TFL
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 02, 2024
Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity.
Journal: Cancer immunology, immunotherapy : CII
Published: September 22, 2024
Sensitivity and Specificity of Chimerism Tests in Predicting Leukemia Relapse Using Increasing Mixed Chimerism.
Journal: The Journal of molecular diagnostics : JMD
Published: April 17, 2024
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation.
Journal: Leukemia research
Published: February 12, 2024
The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: December 01, 2023
Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia.
Journal: International journal of molecular sciences
Published: December 01, 2023
Last Updated: 09/26/2026